This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
Freelance translator and/or interpreter, Verified site user
Data security
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
Affiliations
This person is not affiliated with any business or Blue Board record at ProZ.com.
Open to considering volunteer work for registered non-profit organizations
Rates
Payment methods accepted
Visa
Portfolio
Sample translations submitted: 1
English to Chinese: Drug Prescribing Information Detailed field: Medical: Pharmaceuticals
Source text - English Liver Function:
X has been associated with a reversible, dose-related increase in aspartate aminotransferase (AST) and alanine aminotranferase (ALT), accompanied in some cases by elevated bilirubin. Increases in liver enzymes usually occurred within the first 16 weeks following initiation of treatment and returned to pre-treatment levels without sequelae within a few days to 9 weeks, either spontaneously or after dose reduction or discontinuation.
Liver transaminase levels must be measured prior to initiation of treatment and subsequently at monthly intervals for the first 12 months and quarterly thereafter.
Preexisting Liver Impairment:
Use in patients with baseline values of liver transaminases, i.e., aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT), greater than 3 times the upper limit of normal (ULN), particularly when the total bilirubin is increased togreater than 2 times the ULN, is contraindicated (see CONTRAINDICATIONS).
Management of Patients with Increased Liver Transaminases:
Treatment and monitoring recommendations are as follows:
ALT/AST levels > 3 and 5 ULN
Confirm by another liver function test; if confirmed, reduce the daily dose or stop treatment, monitor aminotransferase levels at least every 2 weeks. If the minotransferase levels return to pre-treatment values consider continuing or reintroducing Y as appropriate (see Reintroduction of treatment below).
ALT/AST levels > 8 x ULN
Treatment must be stopped and reintroduction of Y is not to be considered.
In the case of elevations of aminotransferases accompanied by clinical symptoms of liver injury (such as nausea, vomiting, fever, abdominal pain, jaundice or unusual lethargy or fatigue) or of increases in bilirubin 2 x ULN, treatment must be stopped and reintroduction of Y is not to be considered.
Translation - Chinese 肝功能：
X伴随可逆性、剂量相关的天冬氨酸转氨酶(AST)和丙氨酸转氨酶(ALT)增加, 在某些病例中还伴随有胆红素升高。肝酶通常在开始治疗前16周内升高, 然后在数天至9周内或者自行恢复，或者在减少剂量或者停药后恢复到治疗前水平，无后遗症。
English to Chinese (National Accreditation Authority for Translators and Interpreters)
Memberships
N/A
Software
Adobe Acrobat, Microsoft Excel, Microsoft Word, Powerpoint
Bio
Completed the Post Graduate Diploma course in Translation and Interpreting in Western Sydney University in 2004.
I have studied, worked and lived in Sydney for the last 18 years and translation work has remained my passion. I've been working as a freelance translator on and off for the last 14 years, mainly specialised in the medial and legal areas.
Medical Translation: pharmaceutical manuals, drug prescription information, drug trial research paper, medical treatment records and documentation, medical insurance policies.
Legal Translation: Legal contracts, affidavits.
Others: business documents, marketing and promotional materials, questionnaires, travel guides, education brochures, personal documents.
Keywords: medical, legal, children's book, quality translation, reliable service
Expertise